Due to the impact of Hurricane Florence on the east coast, delivery services by national carriers have been interrupted.
Asia
Europe, Middle East, Africa
North America
ALERT: Hurricane Florence - Shipping & Order Update
12 September, 2018
bioMérieux – First-Half 2018 Results
06 September, 2018
The Board of Directors of bioMérieux, a world leader in the field of in vitro diagnostics, met on September 4 under the chairmanship of Alexandre Mérieux and approved the consolidated financial statements for the six months ended June 30, 2018. The statements had been reviewed by the Statutory Auditors.
Labor Day Shipping Schedule
22 August, 2018
bioMérieux, Inc. sites in Durham, St. Louis, Louisville and Lombard will be closed on Monday, September 3, in observance of the upcoming holiday.
bioMérieux Inc. receives IMV Clinical ServiceTrak™ Awards
31 July, 2018
bioMérieux, Inc. was recognized for Best Customer Satisfaction and Best Service in the ID/AST category, as well as Best System Performance, Best Customer Satisfaction and Best Service in the Blood Culture category.
Independence Day Shipping Schedule
25 June, 2018
bioMérieux Inc. sites in Durham, St. Louis, Louisville and Lombard will be closed on Wednesday, July 4, in observance of the Independence Day holiday.
Memorial Day Shipping Schedule
15 May, 2018
bioMérieux Inc. sites in Durham, St. Louis, Louisville and Lombard will be closed on Monday, May 28 in observance of Memorial Day.
bioMérieux reinforces its offering of High Medical Value immunoassay biomarkers with the acquisition of Astute Medical
04 April, 2018
bioMérieux, a world leader in the field of in vitro diagnostics, announces today the acquisition of Astute Medical Inc., a company dedicated to improving the diagnosis of high-risk medical conditions and diseases through the identification and validation of protein biomarkers.
Lord Jim O’Neill joins bioMérieux in a knowledge exchange on the challenge of antimicrobial resistance
07 March, 2018
Marcy l'Etoile, France, March 7, 2017 - bioMérieux, a world leader in infectious disease diagnostics, committed to the fight against antimicrobial resistance (AMR), organized today a panel discussion with Lord Jim O’Neill, an influential economist, politician and philanthropist who chaired the Review on Antimicrobial Resistance.
bioMérieux - 2017 Financial Results
28 February, 2018
February 28, 2016 – The Board of Directors of bioMérieux, a world leader in the field of in vitro diagnostics, met on February 27 under the chairmanship of Alexandre Mérieux and approved the audited consolidated financial statements for the year ended December 31, 2017.
bioMérieux – Fourth-Quarter 2017 Business Review
23 January, 2018
Marcy l'Étoile, January 23, 2018 – bioMérieux, a world leader in the field of in vitro diagnostics, today released its business review for the twelve months ended December 31, 2017.